Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma.
Mahmoud M A ElsayedMahmoud E MostafaEman AlaaeldinHatem Aa SarhanMontaser ShA ShaykoonShady AllamAhmed Rh AhmedBakheet E M ElsadekPublished in: International journal of nanomedicine (2019)
Our results firmly suggest the distinctive cancer-suppressive nature of CNTs-SFN-MCs, both against HepG2 cells in vitro and in a DENA-induced HCC rat model in vivo, with a preferential superiority over conventional sorafenib.